Holoeyes Transitions to New Management Structure for 2030 Implementation

Holoeyes Inc., based in Minato, Tokyo, is renowned for its advancements in medical image analysis and extended reality (XR) technologies. On January 1, 2026, Takeshi Hosoki, the Chief Innovation Officer (CIO) and head of the Business Promotion Department, has been appointed as a board member. This addition to the leadership team alongside CEO Maki Sugimoto and Director Kenichi Niinjo aims to reinforce the company’s governance and accelerate business growth and societal application with a focus on 2030.

Context and Purpose of the New Management Structure

2026 marks the beginning of a newly formulated five-year mid-term plan for Holoeyes. The company aims to reach a stage where its services are genuinely integrated into society by the fiscal year 2030. Within this timeline, the next two years have been categorized as a "scale-up period," where various management elements are to be enhanced.

Hosoki, who previously led the establishment of business foundations as CIO, will expand his influence across the company’s operations, promoting innovation at all levels. This role is designed to elevate Holoeyes' corporate value from multiple dimensions. As a new board member, Hosoki is expected to not only lead business executions but also drive the expansion of business revenue and overall corporate value.

Takeshi Hosoki's Comments

Reflecting on this new role, Hosoki expressed, "I feel a great sense of responsibility as I take on this important position. The key mission of a board member involves expanding business revenue, but I believe this is not merely about chasing sales targets. The essence of Holoeyes’ existence itself raises corporate value from various angles, leading to scale-up. I am confident that this process will connect deeply with our ultimate goals. My mission is to update the perspectives and standards of both our organization and individuals to ensure steady revenue expansion that will substantially enhance Holoeyes’ corporate value."

Scale for Scale-up

With an innovative viewpoint, Hosoki is poised to propel Holoeyes forward with a new set of metrics that break the mold of conventional thinking, thus creating corporate value that exceeds stakeholder expectations.

Maki Sugimoto’s Comments

Maki Sugimoto, the CEO, stated, "With Hosoki's addition as a board member, we have evolved into a new structure that accelerates our scale-up efforts. His high-level perspective and execution capabilities will undoubtedly take our revenue base and corporate culture to the next stage. We will fortify our management structure and devote ourselves to maximizing corporate value that paves the way for the future of healthcare."

Background on Takeshi Hosoki

For over 20 years, Takeshi Hosoki was involved in new business development in the entertainment industry. In 2018, he joined the VR development venture, Jolly Good Inc., leading the medical education business as an executive officer. By 2024, he had taken on leadership roles at AI medical device venture Iris Inc. and established Project-H, focusing on business development in the healthcare and digital technology sectors. In May 2025, Hosoki officially joined Holoeyes, becoming the Chief Innovation Officer in June that same year.

About Holoeyes

Founded in 2016, Holoeyes is dedicated to optimizing healthcare by spatially recreating and sharing medical images and insights. Its flagship product, Holoeyes MD, processes medical images in 3D, enhancing training and education in the clinical field. As of late 2024, Holoeyes will launch Holoeyes Biz, a corporate service offering comprehensive support for XR content production and operational solutions. The company is also focusing on implementing its services internationally, with ventures into countries including Saudi Arabia and others in the Middle East.

For more information, visit Holoeyes.